Sean Ainsworth

Sean Ainsworth

Chief Executive Officer at Immusoft

Sean Ainsworth is CEO and Chairman at Immusoft. He was Executive Director, Clinical Development at Allergan, CEO and Founder at RetroSense Therapeutics, CEO at GeneVivo, LLC, and VP, Corporate Development at Compendia Bioscience. He is a Board Member at Ray Therapeutics, Inc. and Opus Genetics.

  • Immusoft logo
    Immusoft Executive Officer, Director 2018–present, Chief Executive Officer 2018–present · current
  • Ray Therapeutics, Inc. Board Member 2021–present · current
  • Opus Genetics Board Member 2018–present · current
  • Allergan Executive Director, Clinical Development 2016–2017 · past
  • RetroSense Therapeutics CEO and Founder 2009–2016 · past
  • GeneVivo, LLC CEO 2007–2008 · past
  • Compendia Bioscience VP, Corporate Development 2006 · past
  • Ainsworth BioConsulting Principal 2004–2012 · past
  • The Mattson Jack Group Associate Consultant - Corporate Development 2001–2004 · past

Education

  • Washington University in St. Louis - Olin Business School MBA, Strategy & Finance · 2000–2002
  • UC San Diego B.S., Microbiology · 1992–1996

Online